Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Contemp Clin Trials. 2012 May 19;33(5):993–1002. doi: 10.1016/j.cct.2012.05.003

Table 3.

Power to detect a treatment effect size of .4 or .3 as a function of sample size, difference between treatment arms, and standard deviation

Mean and SD of Buspirone Arm for Cohen’s d of .4
Sample Size Mean=20, SD =15
Diff* = 6 days
Mean=18, SD=10
Diff = 4 days
Mean=16, SD =5
Diff = 2 days
150 77% (19%) 71% 69%
200 86% (12%) 81% 81%
250 92% (7%) 89% 89%

Mean and SD of Buspirone Arm for Cohen’s d of .3
Sample Size Mean=18.5, SD =15
Diff* = 4.5 days
Mean=17, SD=10
Diff = 3 days
Mean=15.5, SD =5
Diff = 1.5 days
250 74% 68% 67%
300 81% 75% 74%
350 86% 81% 80%

Note:

*

Difference in days is equal to the difference between the mean maximum days of continuous cocaine abstinence in the buspirone and placebo arms. Parenthesized figures indicate percent of cases that failed to converge, when convergence failure rates exceeded 5%.